2006년부터 2008년까지 3년간 시판 수산물 2,239건에서 분리한 V. parahaemolyticus에 대한 항생제 감수성 결과는 다음과 같았다. 어류 789건을 검사하여 42주(5.3%)의 V. parahaemolyticus가 분리 동정되었으며, 패류 735건 중 27건(3.7%), 연체류 387건 중 12건(3.1%), 기타 수산물 328건 중 12건(3.7%), 총 93건(4.2%)에서 V. parahaemolyticus가 분리 동정되었다. 내성률이 높은 항생제는 ampicillin 93.5%, cephalothin 90.3%, streptomycin 87.1%, ticarcillin 55.9%, 그리고 amikacin 40.9%이었으며, 감수성률이 높은 항생제는 nalidixic acid, chloramphenicol 및 ampicillin/sulbactam trimethoprim/sulfamethoxazole 98.9%, gentamicin 및 tetracycline 82.8%, ceftriaxone 63.4%이었다. 중등도 내성률은 kanamycin 79.6%, ciprofloxacin 64.5%, amikacin 47.3%, cefoxitin 43.0%순이었다. 항생제 내성양상은 3제 내성이 37.6%, 4제 내성 24.7%, 5제 내성 17.2%, 6제 내성 11.8%, 2제 내성6.5%, 7제 내성 2.2% 순이었으며, 가장 많은 내성 양상은 AM-CF-S의 3제 내성(22.6%), AM-CF-S-TIC 4제 내성(18.3%), AM-AN-CF-S-TIC 5제 내성(9.7%) 순이었다.
Ninety three strains (4.2%) of Vibrio parahaemolyticus were isolated from 2,239 samples of commercial marine products during 2006-2008 in Seoul, Korea. We examined 16 antimicrobial susceptibilities of 93 V. parahaemolyticus isolates. Antibiotic resistance of V. parahaemolyticus was most frequently observed to ampicillin (93.5%), followed by cephalothin (90.3%), streptomycin (87.1%), ticarcillin (55.9%), and amikacin (40.9%). Antibiotic susceptibility was most frequently observed to nalidixic acid, chloramphenicol and ampicillin/sulbactam (100%), followed by trimethoprim/sulfamethoxazole (98.9%), gentamicin and tetracycline (82.8%), and ceftriaxone (63.4%). In addition, the isolates also displayed intermediate resistance to kanamycin (79.6%), ciprofloxacin (64.5%), amikacin (47.3%) and cefoxitin (43.0%). All isolates were resistant to more than two drugs. The most prominent multiple drug resistance was 3 drug resistance (37.6%), followed by 4 drug (24.7%), 5 drug (17.2%), and 6 drug resistance (11.8%). The most prominent multiple drug resistance pattern was the cephalothin-streptomycin-ampicillin resistance pattern (22.6%), followed by cephalothinticarcillin- streptomycin-ampicillin (18.3%) and cephalothin-ticarcillin-streptomycin-ampicillin-amikacin (9.7%). Multiple drug resistance patterns of V. parahaemolyticus from marine products require continuous monitoring.